PML‐RARA transcript levels at the end of induction therapy are associated with prognosis in non‐high‐risk acute promyelocytic leukaemia with all‐ trans retinoic acid plus arsenic in front‐line therapy: long‐term follow‐up of a single‐centre cohort study-Reference-Cited by-同舟云学术

PML‐RARA transcript levels at the end of induction therapy are associated with prognosis in non‐high‐risk acute promyelocytic leukaemia with all‐ trans retinoic acid plus arsenic in front‐line therapy: long‐term follow‐up of a single‐centre cohort study

Published:2021-08-17 Issue:5 Volume:195 Page:722-730
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Tang Fei‐Fei¹,Lu Sheng‐Ye¹^ORCID,Zhao Xiao‐Su¹,Qin Ya‐Zhen¹^ORCID,Liu Xiao‐Hong¹,Jia Jin‐Song¹^ORCID,Wang Jing¹,Gong Li‐Zhong¹,Jiang Qian¹^ORCID,Zhao Ting¹,Shi Hong‐Xia¹,Chang Ying-Jun¹,Huang Xiao-Jun¹²³^ORCID,Jiang Hao¹^ORCID

Affiliation:

1. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation BeijingChina

2. Peking‐Tsinghua Center for Life Sciences BeijingChina

3. Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies Chinese Academy of Medical Sciences Beijing China

Funder

Beijing Municipal Science and Technology Commission

National Science and Technology Major Project

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17752

Reference28 articles.